{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:55:36Z","timestamp":1789419336016,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth Analg Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The role of \u03b2-blockers in the critically ill has been studied, and data on the protective effects of these drugs on critically ill patients have been repeatedly reported in the literature over the last two decades. However, consensus and guidelines by scientific societies on the use of \u03b2-blockers in critically ill patients are still lacking.<\/jats:p>\n                    <jats:p>The purpose of this document is to support the clinical decision-making process regarding the use of \u03b2-blockers in critically ill patients. The recipients of this document are physicians, nurses, healthcare personnel, and other professionals involved in the patient\u2019s care process.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) selected a panel of experts and asked them to define key aspects underlying the use of \u03b2-blockers in critically ill adult patients. The methodology followed by the experts during this process was in line with principles of modified Delphi and RAND-UCLA methods. The experts developed statements and supportive rationales in the form of informative text. The overall list of statements was subjected to blind votes for consensus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The literature search suggests that adrenergic stress and increased heart rate in critically ill patients are associated with organ dysfunction and increased mortality. Heart rate control thus seems to be critical in the management of the critically ill patient, requiring careful clinical evaluation aimed at both the differential diagnosis to treat secondary tachycardia and the treatment of rhythm disturbance. In addition, the use of \u03b2-blockers for the treatment of persistent tachycardia may be considered in patients with septic shock once hypovolemia has been ruled out. Intravenous application should be the preferred route of administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\u03b2-blockers protective effects in critically ill patients have been repeatedly reported in the literature. Their use in the acute treatment of increased heart rate requires understanding of the pathophysiology and careful differential diagnosis, as all causes of tachycardia should be ruled out and addressed first.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s44158-023-00126-2","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T07:01:43Z","timestamp":1698044503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The role of beta-blocker drugs in critically ill patients: a SIAARTI expert consensus statement"],"prefix":"10.1186","volume":"3","author":[{"given":"Fabio","family":"Guarracino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1416-9993","authenticated-orcid":false,"given":"Andrea","family":"Cortegiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Behr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giandomenico","family":"Biancofiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Del Gaudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Forfori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Galdieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Grasselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Paternoster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Romagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Sardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Treskatsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo Francesco","family":"Tripodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Tritapepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"key":"126_CR1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1164\/ajrccm.160.2.9810073","volume":"160","author":"D Annane","year":"1999","unstructured":"Annane D, Trabold F, Sharshar T, Jarrin I, Blanc AS, Raphael JC, Gajdos P (1999) Inappropriate sympathetic activation at onset of septic shock\u2013a spectral analysis approach. Am J Respir Crit Care Med 160:458\u2013465","journal-title":"Am J Respir Crit Care Med"},{"key":"126_CR2","doi-asserted-by":"crossref","unstructured":"Vincent JL, Zhang H, Szabo C, Preiser JC. Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 161: 1781\u20131785, 2000. 38. Voss LJ, Bolton DPG, Galland BC, Taylor BJ. Endotoxin effects on markers of autonomic nervous system function in the piglet: implications for SIDS. Biol Neonate.\u00a02004;86:39\u2013 47 .","DOI":"10.1159\/000077452"},{"issue":"11","key":"126_CR3","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, M\u00f8ller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 47(11):1181\u20131247","journal-title":"Intensive Care Med."},{"key":"126_CR4","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus DC, van der Poll T (2013) Severe sepsis and septic shock. N Engl J Med. 369:840\u201351","journal-title":"N Engl J Med."},{"key":"126_CR5","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1093\/cvr\/cvab240","volume":"118","author":"A Petraina","year":"2022","unstructured":"Petraina A, Nogales C, Krahn T, Mucke H, L\u00fcscher TF, Fischmeister R, Kass DA, Burnett JC, Hobbs AJ, Schmidt HHHW (2022) Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology. Cardiovasc Res 118:2085\u20132102","journal-title":"Cardiovasc Res"},{"issue":"18","key":"126_CR6","first-page":"e117","volume":"107","author":"B-A Blockers","year":"2003","unstructured":"Blockers B-A (2003) William H. Frishman. Circulation 107(18):e117\u2013e119","journal-title":"Circulation"},{"key":"126_CR7","doi-asserted-by":"crossref","unstructured":"Wo\u0142owiec L, Grzegorz Grze\u015bk, Osiak J, Wijata A, M\u0119dlewska M, Gaborek P, Banach J, Wo\u0142owiec A, G\u0142owacka M. Beta-blockers in cardiac arrhythmias\u2013clinical pharmacologist\u2019s point of view. Front Pharmacol. 2022;13:1043714.","DOI":"10.3389\/fphar.2022.1043714"},{"issue":"9","key":"126_CR8","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2105\/AJPH.74.9.979","volume":"74","author":"A Fink","year":"1984","unstructured":"Fink A, Kosecoff J, Chassin M, Brook RH (1984) Consensus methods: characteristics and guidelines for use. Am J Public Health 74(9):979\u2013983","journal-title":"Am J Public Health"},{"key":"126_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 88:105906","journal-title":"Int J Surg"},{"key":"126_CR10","unstructured":"The RAND\/UCLA Appropriateness Method User\u2019s Manual | RAND. https:\/\/www.rand.org\/pubs\/monograph_reports\/MR1269.html. Accessed 24 Apr 2023."},{"key":"126_CR11","doi-asserted-by":"crossref","unstructured":"Spence JD, Noncardiac surgery KS. The devil is in the details. Anesthesiology. 2023;138(1):7\u20139.","DOI":"10.1097\/ALN.0000000000004441"},{"issue":"1","key":"126_CR12","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1080\/07853890.2022.2098376","volume":"54","author":"M Heliste","year":"2022","unstructured":"Heliste M, Pettil\u00e4 V, Berger D, Jakob SM, Wilkman E (2022) Beta-blocker treatment in the critically ill: a systematic review and meta-analysis. Ann Med. 54(1):1994\u20132010","journal-title":"Ann Med."},{"issue":"4","key":"126_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/SHK.0000000000000426","volume":"44","author":"C Martin","year":"2015","unstructured":"Martin C, Medam S, Antonini F, Alingrin J, Haddam M, Hammad E et al (2015) Norepinephrine: not too much, too long. Shock 44(4):305\u2013309. https:\/\/doi.org\/10.1097\/SHK.0000000000000426","journal-title":"Shock"},{"key":"126_CR14","doi-asserted-by":"crossref","unstructured":"Vellinga N A R, Boerma E C, Koopmans M, Donati A, Dubin A, Shapiro N I, et al. and microSOAP Study Group. International study on microcirculatory shock occurrence in acutely ill patients. Crit Care Med. 2015;43(1):48\u201356.","DOI":"10.1097\/CCM.0000000000000553"},{"key":"126_CR15","doi-asserted-by":"publisher","unstructured":"Habimana R, Choi I, Cho H J, Kim D, Lee K, Jeong I. Sepsis-induced cardiac dysfunction: a review of pathophysiology. Acute and Critical Care. 2020;35(2):57-66.\u00a0\u00a0https:\/\/doi.org\/10.4266\/acc.2020.00248","DOI":"10.4266\/acc.2020.00248"},{"issue":"2","key":"126_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10877-020-00534-7","volume":"35","author":"RF Trauzeddel","year":"2021","unstructured":"Trauzeddel RF, Ertmer M, Nordine M, Groesdonk HV, Michels G, Pfister R et al (2021) Perioperative echocardiography-guided hemodynamic therapy in high-risk patients: a practical expert approach of hemodynamically focused echocardiography. J Clin Monit Comput 35(2):229\u2013243. https:\/\/doi.org\/10.1007\/s10877-020-00534-7. (Epub 2020 May 26)","journal-title":"J Clin Monit Comput"},{"key":"126_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.itjm.2010.03.009","volume":"4","author":"M Ongari","year":"2013","unstructured":"Ongari M, Boriani G (2013) Tachycardia-related cardiomyopathy: a review of the literature. Ital J Med 4:92\u201398","journal-title":"Ital J Med"},{"issue":"2","key":"126_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/cc12522]7","volume":"17","author":"F Guarracino","year":"2013","unstructured":"Guarracino F, Baldassarri R, Pinsky MR (2013) Ventriculo-arterial decoupling in acutely altered hemodynamic states. Crit Care 17(2):213. https:\/\/doi.org\/10.1186\/cc12522]7","journal-title":"Crit Care"},{"key":"126_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000004404","author":"NL McKenzie","year":"2023","unstructured":"McKenzie NL, Ward RP, Nagele P, Rubin DS (2023) Preoperative \u03b2-blocker therapy and stroke or major adverse cardiac events in major abdominal surgery: a retrospective cohort study. Anesthesiology. https:\/\/doi.org\/10.1097\/ALN.0000000000004404","journal-title":"Anesthesiology"},{"key":"126_CR20","doi-asserted-by":"publisher","unstructured":"POISE Study Group* (P J Devereaux, H Yang, S Yusuf, G Guyatt, K Leslie, J C Villar, D Xavier, S Chrolavicius, L Greenspan, J Pogue, P Pais, L Liu, S Xu, G M\u00e1laga, A Avezum, M Chan, V M Montori, M Jacka, P Choi). Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839\u201347.\u00a0https:\/\/doi.org\/10.1016\/S0140-6736(08)60601-7.","DOI":"10.1016\/S0140-6736(08)60601-7"},{"issue":"9","key":"126_CR21","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S2213-2600(20)30063-1","volume":"8","author":"A Morelli","year":"2020","unstructured":"Morelli A, Whitehouse T, Rehberg S (2020) \u03b2-blockade in sepsis: regulation of persisting sepsis-related tachycardia. Lancet Respir Med 8(9):833\u2013834. https:\/\/doi.org\/10.1016\/S2213-2600(20)30063-1","journal-title":"Lancet Respir Med"},{"key":"126_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.278477","author":"A Morelli","year":"2013","unstructured":"Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S et al (2013) Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. https:\/\/doi.org\/10.1001\/jama.2013.278477","journal-title":"JAMA"},{"issue":"10","key":"126_CR23","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1007\/s00134-016-4351-2","volume":"42","author":"A Morelli","year":"2016","unstructured":"Morelli A, Singer M, Ranieri VM, D\u2019Egidio A, Mascia L, Orecchioni A et al (2016) Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study. Intensive Care Med. 42(10):1528\u20131534","journal-title":"Intensive Care Med."},{"key":"126_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.01.009","author":"D Hasegawa","year":"2021","unstructured":"Hasegawa D, Sato R, Prasitlumkum N, Nishida K, Takahashi K, Yatabe T et al (2021) Effect of ultrashort-acting \u03b2-blockers on mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: a systematic review and meta-analysis of randomized controlled trials. Chest. https:\/\/doi.org\/10.1016\/j.chest.2021.01.009","journal-title":"Chest"},{"issue":"4","key":"126_CR25","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.chest.2020.10.049","volume":"59","author":"NA Bosch","year":"2021","unstructured":"Bosch NA, Rucci JM, Massaro JM, Winter MR, Quinn EK, Chon KH et al (2021) Comparative effectiveness of heart rate control medications for the treatment of sepsis-associated atrial fibrillation. Chest. 59(4):1452\u20131459","journal-title":"Chest."},{"issue":"5","key":"126_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s40261-019-00762-z","volume":"39","author":"YR Lee","year":"2019","unstructured":"Lee YR, Seth MS, Soney D, Dai H (2019) Benefits of beta-blockade in sepsis and septic shock: a systematic review. Clin Drug Investig 39(5):429\u2013440. https:\/\/doi.org\/10.1007\/s40261-019-00762-z","journal-title":"Clin Drug Investig"},{"key":"126_CR27","doi-asserted-by":"publisher","unstructured":"Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, et al. (2022). ESC Scientific Document Group. 2022 ESC guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J.\u00a0https:\/\/doi.org\/10.1093\/eurheartj\/ehac270.","DOI":"10.1093\/eurheartj\/ehac270"},{"key":"126_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa733","author":"A Clemente-Morag\u00f3n","year":"2020","unstructured":"Clemente-Morag\u00f3n A, G\u00f3mez M, Villena-Guti\u00e9rrez R, Lalama DV, Garc\u00eda-Prieto J, Mart\u00ednez F et al (2020) Metoprolol exerts a non-class effect against ischaemia-reperfusion injury by abrogating exacerbated inflammation. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa733","journal-title":"Eur Heart J"},{"key":"126_CR29","doi-asserted-by":"crossref","unstructured":"Morelli A, Romano SM, Sanfilippo F, Santonocito C, Frati G, Marco Chiostri, Agr\u00f2 FE, Ertmer C, Rehberg SW, Vieillard-Baron A. (2020). Systolic-dicrotic notch pressure difference can identify tachycardic patients with septic shock at risk of cardiovascular decompensation following pharmacological heart rate reduction. Br J Anaesth. 125(6):1018\u20131024.","DOI":"10.1016\/j.bja.2020.05.058"},{"key":"126_CR30","doi-asserted-by":"crossref","unstructured":"Longrois D, Couffignal C, Ait-Hamou N, Amour J, Cholley B, Dilly M. (2015). Indispensable optimisation de la r\u00e9introduction des b\u00eatabloquants apr\u00e8s chirurgie cardiaque. R\u00e9sultats de l\u2019\u00e9tude B\u00eatabloquants Avant et Apr\u00e8s Chirurgie Cardiaque (BBAACC. Anesth R\u00e9animation. 1:A248.","DOI":"10.1016\/j.anrea.2015.07.379"},{"key":"126_CR31","doi-asserted-by":"crossref","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. 1;42(5):373\u2013498.","DOI":"10.1093\/eurheartj\/ehab648"},{"key":"126_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03684-5","author":"L Drikite","year":"2021","unstructured":"Drikite L, Bedford JP, O\u2019Bryan L, Petrinic T, Rajappan K, Doidge J et al (2021) Treatment strategies for new onset atrial fibrillation in patients treated on an intensive care unit: a systematic scoping review. Crit Care. https:\/\/doi.org\/10.1186\/s13054-021-03684-5","journal-title":"Crit Care"},{"key":"126_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2018.03.009","author":"M Brown","year":"2018","unstructured":"Brown M, Nassoiy S, Chaney W, Plackett TP, Blackwell RH, Luchette F et al (2018) Impact and treatment success of new-onset atrial fibrillation with rapid ventricular rate development in the surgical intensive care unit. J Surg Res. https:\/\/doi.org\/10.1016\/j.jss.2018.03.009","journal-title":"J Surg Res"},{"key":"126_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2017.04.027","author":"M Balik","year":"2017","unstructured":"Balik M, Kolnikova I, Maly M, Waldauf P, Tavazzi G, Kristof J (2017) Propafenone for supraventricular arrhythmias in septic shock-comparison to amiodarone and metoprolol. J Crit Care. https:\/\/doi.org\/10.1016\/j.jcrc.2017.04.027","journal-title":"J Crit Care"},{"key":"126_CR35","doi-asserted-by":"publisher","unstructured":"Clemo HF, Wood MA, Gilligan DM, Ellenbogen KA. (1998). Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. Am J Cardiol. .1;81(5):594\u20138.\u00a0https:\/\/doi.org\/10.1016\/s0002-9149(97)00962-4.","DOI":"10.1016\/s0002-9149(97)00962-4"},{"issue":"6","key":"126_CR36","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/00003246-200106000-00011","volume":"29","author":"G Delle Karth","year":"2001","unstructured":"Delle Karth G, Geppert A, Neunteufl T, Priglinger U, Haumer M, Gschwandtner M, Siostrzonek P, Heinz G (2001) Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias. Crit Care Med 29(6):1149\u20131153. https:\/\/doi.org\/10.1097\/00003246-200106000-00011. (PMID: 11395591)","journal-title":"Crit Care Med"},{"key":"126_CR37","doi-asserted-by":"publisher","unstructured":"Hou ZY, Chang MS, Chen CY, Tu MS, Lin SL, Chiang HT, et al. 1995. Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study. Eur Heart J.\u00a0\u00a0https:\/\/doi.org\/10.1093\/oxfordjournals.eurheartj.a060945.","DOI":"10.1093\/oxfordjournals.eurheartj.a060945"},{"key":"126_CR38","doi-asserted-by":"publisher","DOI":"10.1177\/0885066617696847","author":"Y Launey","year":"2019","unstructured":"Launey Y, Lasocki S, Asehnoune K, Gaudriot B, Chassier C, Cinotti R et al (2019) Impact of low-dose hydrocortisone on the incidence of atrial fibrillation in patients with septic shock: a propensity score-inverse probability of treatment weighting cohort study. J Intensive Care Med. https:\/\/doi.org\/10.1177\/0885066617696847","journal-title":"J Intensive Care Med"},{"key":"126_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40560-021-00552-w","volume":"9","author":"D Hasegawa","year":"2021","unstructured":"Hasegawa D, Sato R, Nishida O (2021) \u03b21-blocker in sepsis. J Intensive Care 9:39","journal-title":"J Intensive Care"},{"key":"126_CR40","doi-asserted-by":"crossref","unstructured":"Walkey AJ, Evans W SR, MR B, E.J. (2016). Practice patterns and outcomes of treatments for atrial fibrillation during sepsis: a propensity-matched cohort study. Chest.149(1):74\u201383.","DOI":"10.1378\/chest.15-0959"},{"key":"126_CR41","doi-asserted-by":"publisher","unstructured":"Okajima M, Takamura M, Taniguchi T. (2015). Landiolol, an ultra-short-acting \u03b21-blocker, is useful for managing supraventricular tachyarrhythmias in sepsis. World J Crit Care Med. 4;4(3):251\u20137. https:\/\/doi.org\/10.5492\/wjccm.v4.i3.251.","DOI":"10.5492\/wjccm.v4.i3.251"}],"container-title":["Journal of Anesthesia, Analgesia and Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-023-00126-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s44158-023-00126-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s44158-023-00126-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T05:03:13Z","timestamp":1700629393000},"score":1,"resource":{"primary":{"URL":"https:\/\/janesthanalgcritcare.biomedcentral.com\/articles\/10.1186\/s44158-023-00126-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["126"],"URL":"https:\/\/doi.org\/10.1186\/s44158-023-00126-2","relation":{},"ISSN":["2731-3786"],"issn-type":[{"value":"2731-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,23]]},"assertion":[{"value":"28 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}